Viewing Study NCT00006669


Ignite Creation Date: 2025-12-24 @ 10:54 PM
Ignite Modification Date: 2025-12-25 @ 8:22 PM
Study NCT ID: NCT00006669
Status: WITHDRAWN
Last Update Posted: 2021-10-27
First Post: 2000-12-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Rituximab Followed by Combination Chemotherapy in Treating Patients With Refractory or Recurrent Non-Hodgkin's Lymphoma
Sponsor: Medstar Health Research Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module